Completed Trials

AHCC08

Find out how the INSIGHT study tracked real-world HCC diagnosis and treatment across Asia-Pacific, with findings published in *Liver Cancer* and presented at major international conferences.

AHCC07

Explore the PLANet Study (AHCC 07), a multi-centre Asia-Pacific research effort using precision medicine to improve liver cancer outcomes.

AHCC06

Read about the SIRveNIB trial, a completed Phase III study comparing SIRT and Sorafenib for liver cancer across Asia-Pacific centres.

AHCC05

Read about the AHCC 05 trial, a completed Phase I/II study on SIR-Spheres plus Sorafenib as first-line treatment for non-resectable hepatocellular carcinoma.

AHCC 04

Find out about the completed Phase II dose escalating trial of intra-tumoral BrachySil in unresectable hepatocellular carcinoma, with results published in a leading oncology journal.

AHCC 03

Find out about the AHCC 03 trial, a completed study on adjuvant intra-arterial radioactive iodine after liver cancer surgery, including its findings and key investigators.

AHCC02

Find out about the AHCC 02 trial, a completed study testing Megestrol Acetate for inoperable liver cancer, and access its published results.

AHCC01

Find out about the AHCC 01 trial, a completed randomised study comparing tamoxifen with placebo for inoperable liver cancer, with results published in *Hepatology* in 2002.